Branch retinal vein occlusion on Coats disease during COVID-19 infection: a case report
DOI:
https://doi.org/10.31288/oftalmolzh202236364Keywords:
covid-19, Coats disease, branch retinal vein occlusion, retina, virusAbstract
Background. The COVID-19 virus infection can develop ocular manifestations.
Purpose. To report a case of a coats disease patient who was evaluated one week before as part of a routine retinal consultation and later had COVID-19 with sudden loss of vision on one eye.
Material and Methods. the affected eye had a visual acuity of 20/400. At fundus examination was found abnormal tortuous vasculature, hemorrhages, branch retinal vein occlusion and macular edema. It was confirm with fluorescein angiography and optical coherence tomography.
Results. With a combined therapy of intravitreal Aflibercept, periocular triamcinolone and focal laser was recovery the visual acuity to 20/20.
Conclusion. There are few cases describes on literature, but a sudden loss of vision during a COVID-19 infection must be early detected and treated to achieve a better visual acuity recovery.
References
1.Umed Sheth J, Narayanan R, Goyal J, Goyal V. Retinal vein occlusion in COIV-19: a novel entity. Indian Journal of Ophthalmology. 2020;68(10):2291-3. https://doi.org/10.4103/ijo.IJO_2380_20
2.Raval N, Djougarian A, Lin J. Central retinal vein occlusion in the setting of COVID-19 infection. Journal of Opthalmic Inflammation and Infection. 2021;11(10). https://doi.org/10.1186/s12348-021-00241-7
3.Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort Jr R. Retinal findings in patients with COVID-19. The Lancent. 2020;395:1609-10. https://doi.org/10.1016/S0140-6736(20)31014-X
4.Sunny Ch, Callie KL. Central retinal artery occlusion in patients with COVID-19: imaging for underlying causes. Radiology.2020;300:E315-6. https://doi.org/10.1148/radiol.2021210479
5.Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M Colombo V, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. E Clinical Medicine. 2020;100550. https://doi.org/10.1016/j.eclinm.2020.100550
6.Venkatesh R, Gurram Reddy N, Agrawal S, Pereira A. COVID-19 associated central retinal vein occlusion treated with oral aspirin. BMJ Case Rep. 2021;14:e242987. https://doi.org/10.1136/bcr-2021-242987
7.Casagrande M,Fitzek A, Puschel K, Aleshcheva G, Schultheiss HP et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocular Immunology and Inflammation. 2020;28(5):721-25. https://doi.org/10.1080/09273948.2020.1770301
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Leopoldo Garduño Vieyra, Dr., Raúl Rúa Martínez, Dr, Bruno Flores Escobar, Dr.
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
